日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/09 | 1,616 | 1,616 | 1,601 | 1,613 | -12 | -0.7% | 2,100 |
| 2024/09/06 | 1,616 | 1,625 | 1,610 | 1,625 | +10 | +0.6% | 500 |
| 2024/09/05 | 1,616 | 1,624 | 1,615 | 1,615 | -6 | -0.4% | 2,900 |
| 2024/09/04 | 1,634 | 1,640 | 1,621 | 1,621 | -14 | -0.9% | 3,300 |
| 2024/09/03 | 1,634 | 1,635 | 1,634 | 1,635 | +1 | +0.1% | 900 |
| 2024/09/02 | 1,636 | 1,642 | 1,634 | 1,634 | -10 | -0.6% | 2,100 |
| 2024/08/30 | 1,640 | 1,644 | 1,632 | 1,644 | +10 | +0.6% | 1,800 |
| 2024/08/29 | 1,644 | 1,644 | 1,631 | 1,634 | -6 | -0.4% | 800 |
| 2024/08/28 | 1,643 | 1,643 | 1,631 | 1,640 | -1 | -0.1% | 500 |
| 2024/08/27 | 1,630 | 1,641 | 1,628 | 1,641 | -3 | -0.2% | 900 |
| 2024/08/26 | 1,646 | 1,646 | 1,633 | 1,644 | +12 | +0.7% | 2,400 |
| 2024/08/23 | 1,642 | 1,642 | 1,618 | 1,632 | -7 | -0.4% | 1,000 |
| 2024/08/22 | 1,631 | 1,655 | 1,631 | 1,639 | +9 | +0.6% | 2,200 |
| 2024/08/21 | 1,611 | 1,651 | 1,611 | 1,630 | -18 | -1.1% | 1,000 |
| 2024/08/20 | 1,625 | 1,658 | 1,608 | 1,648 | -9 | -0.5% | 4,800 |
| 2024/08/19 | 1,658 | 1,658 | 1,592 | 1,657 | +61 | +3.8% | 12,700 |
| 2024/08/16 | 1,533 | 1,675 | 1,527 | 1,596 | +66 | +4.3% | 14,800 |
| 2024/08/15 | 1,543 | 1,543 | 1,525 | 1,530 | -10 | -0.6% | 1,800 |
| 2024/08/14 | 1,535 | 1,540 | 1,532 | 1,540 | +3 | +0.2% | 3,000 |
| 2024/08/13 | 1,533 | 1,560 | 1,532 | 1,537 | +2 | +0.1% | 2,300 |
| 2024/08/09 | 1,533 | 1,535 | 1,526 | 1,535 | +5 | +0.3% | 1,700 |
| 2024/08/08 | 1,530 | 1,530 | 1,529 | 1,530 | ±0 | ±0% | 600 |
| 2024/08/07 | 1,526 | 1,560 | 1,526 | 1,530 | +4 | +0.3% | 2,100 |
| 2024/08/06 | 1,515 | 1,545 | 1,505 | 1,526 | +6 | +0.4% | 3,900 |
| 2024/08/05 | 1,553 | 1,553 | 1,490 | 1,520 | -41 | -2.6% | 13,800 |
| 2024/08/02 | 1,584 | 1,584 | 1,561 | 1,561 | -41 | -2.6% | 2,200 |
| 2024/08/01 | 1,583 | 1,612 | 1,583 | 1,602 | +28 | +1.8% | 6,200 |
| 2024/07/31 | 1,565 | 1,583 | 1,560 | 1,574 | +24 | +1.5% | 6,000 |
| 2024/07/30 | 1,593 | 1,599 | 1,550 | 1,550 | -43 | -2.7% | 22,700 |
| 2024/07/29 | 1,602 | 1,602 | 1,582 | 1,593 | -9 | -0.6% | 1,500 |
| 2024/07/26 | 1,591 | 1,630 | 1,572 | 1,602 | +25 | +1.6% | 10,200 |
| 2024/07/25 | 1,581 | 1,591 | 1,571 | 1,577 | -7 | -0.4% | 3,500 |
| 2024/07/24 | 1,582 | 1,590 | 1,581 | 1,584 | -12 | -0.8% | 1,100 |
| 2024/07/23 | 1,582 | 1,597 | 1,580 | 1,596 | +14 | +0.9% | 3,500 |
| 2024/07/22 | 1,594 | 1,597 | 1,582 | 1,582 | -15 | -0.9% | 5,700 |
| 2024/07/19 | 1,593 | 1,598 | 1,591 | 1,597 | +9 | +0.6% | 1,900 |
| 2024/07/18 | 1,595 | 1,607 | 1,588 | 1,588 | -12 | -0.8% | 1,600 |
| 2024/07/17 | 1,585 | 1,600 | 1,585 | 1,600 | +15 | +0.9% | 3,200 |
| 2024/07/16 | 1,585 | 1,601 | 1,582 | 1,585 | +1 | +0.1% | 2,600 |
| 2024/07/12 | 1,583 | 1,594 | 1,582 | 1,584 | +2 | +0.1% | 1,400 |
| 2024/07/11 | 1,582 | 1,605 | 1,582 | 1,582 | ±0 | ±0% | 600 |
| 2024/07/10 | 1,595 | 1,607 | 1,582 | 1,582 | -19 | -1.2% | 2,000 |
| 2024/07/09 | 1,600 | 1,601 | 1,597 | 1,601 | -1 | -0.1% | 1,600 |
| 2024/07/08 | 1,627 | 1,627 | 1,600 | 1,602 | ±0 | ±0% | 7,700 |
| 2024/07/05 | 1,604 | 1,627 | 1,600 | 1,602 | -5 | -0.3% | 2,600 |
| 2024/07/04 | 1,608 | 1,631 | 1,607 | 1,607 | -13 | -0.8% | 2,200 |
| 2024/07/03 | 1,623 | 1,640 | 1,620 | 1,620 | -3 | -0.2% | 3,100 |
| 2024/07/02 | 1,628 | 1,630 | 1,611 | 1,623 | -2 | -0.1% | 2,100 |
| 2024/07/01 | 1,618 | 1,630 | 1,617 | 1,625 | +1 | +0.1% | 1,400 |
| 2024/06/28 | 1,600 | 1,624 | 1,598 | 1,624 | +24 | +1.5% | 3,700 |
51～
100
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 21,000円 | - | - | 0.00% | - | 2.85倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,200円 | -97.8% | - | 0.00% | - | 1.49倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,100円 | -43.1% | - | 0.00% | - | 1.85倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 87,800円 | +87.8% | +265.7% | 0.00% | 52.73倍 | 2.42倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
